TET2 c.3803+45G>A

Variant ID: 4-106164980-G-A

NM_001127208.2(TET2):c.3803+45G>A

This variant was identified in 3 publications

View GRCh38 version.




Publications:


TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan.

Peerj
Shaikh, Abdul Rehman Khalil ARK; Ujjan, Ikram I; Irfan, Muhammad M; Naz, Arshi A; Shamsi, Tahir T; Khan, Muhammad Tariq Masood MTM; Shakeel, Muhammad M
Publication Date: 2021

Variant appearance in text: rs17319679
PubMed Link: 33643703
Variant Present in the following documents:
  • Main text
  • peerj-09-10678.pdf
View BVdb publication page



Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.

Scientific Reports
Skowron, Margaretha A MA; Petzsch, Patrick P; Hardt, Karin K; Wagner, Nicholas N; Beier, Manfred M; Stepanow, Stefanie S; Drechsler, Matthias M; Rieder, Harald H; Köhrer, Karl K; Niegisch, Günter G; Hoffmann, Michèle J MJ; Schulz, Wolfgang A WA
Publication Date: 2019-10-09

Variant appearance in text: rs17319679
PubMed Link: 31597922
Variant Present in the following documents:
  • 41598_2019_50891_MOESM9_ESM.xlsx, sheet 1
  • 41598_2019_50891_MOESM8_ESM.xlsx, sheet 1
View BVdb publication page



TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations.

Biomed Research International
Hernández-Sánchez, María M; Rodríguez, Ana Eugenia AE; Kohlmann, Alexander A; Benito, Rocío R; García, Juan Luis JL; Risueño, Alberto A; Fermiñán, Encarna E; De Las Rivas, Javier J; González, Marcos M; Hernández-Rivas, Jesús-María JM
Publication Date: 2014

Variant appearance in text: rs17319679
PubMed Link: 24693539
Variant Present in the following documents:
  • Main text
  • BMRI2014-814294.pdf
View BVdb publication page